Immunity to Covid-19 lost within three months of infection, study suggests
Antibody levels appear to peak a few weeks after illness but then drop swiftly
Patients who have recovered from Covid-19 may lose their newly gained immunity to the coronavirus within months, according to researchers.
In the first study of its kind, scientists at King’s College London who analysed blood samples from more than 90 patients and healthcare workers found that antibodies which can defeat the virus peaked around three weeks after symptoms first appeared, but then rapidly declining.
This suspected loss of immunity means that the virus “could reinfect people year after year, like common colds”, and “has implications for the development of a vaccine, and for the pursuit of ‘herd immunity’”, says The Guardian.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“People are producing a reasonable antibody response to the virus, but it’s waning over a short period of time and depending on how high your peak is, that determines how long the antibodies are staying around,” said lead study author Dr Katie Doores.
The study, which is yet to be peer reviewed, was based on results from 65 patients and six healthcare workers at Guy’s and St Thomas’ NHS Foundation Trust who tested positive for Covid-19, as well as 31 staff who volunteered to have regular antibody tests between March and June.
The blood tests revealed that while 60% of the infected participants developed a “potent” antibody response, just 17% had the same potency three months later. “Antibody levels fell as much as 23-fold over the period”, and became “undetectable” in some cases, the newspaper reports.
The findings come as scientists prepare to begin trials of an “antibody treatment that could be used to protect older people from the coronavirus”, The Times says.
The treatment is being developed by Cambridge-based drugmaker Astrazeneca, which hopes that the “three-minute infusion of antibodies could ward off infection for up to six months”, the newspaper reports.
As well as boosting the immune systems of at-risk older people, the therapy would also provide an option for people who cannot use conventional vaccines because their immune systems are compromised by immunosuppressant drugs or chemotherapy.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joe Evans is the world news editor at TheWeek.co.uk. He joined the team in 2019 and held roles including deputy news editor and acting news editor before moving into his current position in early 2021. He is a regular panellist on The Week Unwrapped podcast, discussing politics and foreign affairs.
Before joining The Week, he worked as a freelance journalist covering the UK and Ireland for German newspapers and magazines. A series of features on Brexit and the Irish border got him nominated for the Hostwriter Prize in 2019. Prior to settling down in London, he lived and worked in Cambodia, where he ran communications for a non-governmental organisation and worked as a journalist covering Southeast Asia. He has a master’s degree in journalism from City, University of London, and before that studied English Literature at the University of Manchester.
-
6 queer poets to read whenever but especially now
The Week Recommends April is National Poetry Month
By Scott Hocker, The Week US Published
-
How women's pain is often ignored in health care
the explainer The gap in care is especially glaring compared to how men are treated
By Theara Coleman, The Week US Published
-
6 serene homes in Vermont
Features Featuring a four-level Shaker barn in Hartland and a Scandinavian-inspired home in Stowe
By The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
China's pneumonia cases: should we be worried?
The Explainer Experts warn against pushing 'pandemic panic button' following outbreak of respiratory illness
By Keumars Afifi-Sabet, The Week UK Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published